U.S. Markets closed

GlaxoSmithKline plc (GSK.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,708.50-13.50 (-0.78%)
At close: 4:35PM BST
Full screen
Previous Close1,722.00
Open1,720.00
Bid1,684.50 x 175400
Ask1,720.00 x 417900
Day's Range1,708.50 - 1,721.50
52 Week Range1,446.50 - 1,745.56
Volume4,340,832
Avg. Volume9,025,728
Market Cap83.47B
Beta1.22
PE Ratio (TTM)50.10
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.00 (4.65%)
Ex-Dividend Date2017-02-23
1y Target EstN/A
  • GSK's new CEO aims to divest sports nutrition brand: sources
    Reuters3 days ago

    GSK's new CEO aims to divest sports nutrition brand: sources

    GlaxoSmithKline Plc's new Chief Executive Officer Emma Walmsley is shaking up the British drugmaker's portfolio of smaller products with plans to divest its MaxiNutrition sports nutrition brand, two people familiar with the matter said on Thursday. GSK bought the business, which makes protein bars, drinks and powders, for 162 million pounds ($205 million) in 2010 under previous CEO Andrew Witty. The original acquisition was seen as complementing GSK's Lucozade sports drinks.

  • Glaxo's (GSK) Shingles Candidate Phase III Data Positive
    Zacks3 days ago

    Glaxo's (GSK) Shingles Candidate Phase III Data Positive

    GlaxoSmithKline plc (GSK) announced positive top-line results from a phase III revaccination study on its shingles vaccine candidate, Shingrix, in older patients.

  • CNBC4 days ago

    Early movers: ORCL, HAIN, ACN, SCS, ATUS, NVS, GSK & more

    These are the stocks posting the largest moves before the bell.